Galenica AG (SWX:GALE)
86.35
+0.35 (0.41%)
Aug 14, 2025, 5:31 PM CET
Galenica AG Revenue
Galenica AG had revenue of 2.00B CHF in the half year ending June 30, 2025, with 7.77% growth. This brings the company's revenue in the last twelve months to 4.03B, up 5.91% year-over-year. In the year 2024, Galenica AG had annual revenue of 3.93B with 4.65% growth.
Revenue (ttm)
4.03B
Revenue Growth
+5.91%
P/S Ratio
1.06
Revenue / Employee
504.07K
Employees
7,971
Market Cap
4.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.93B | 174.55M | 4.65% |
Dec 31, 2023 | 3.76B | 160.81M | 4.47% |
Dec 31, 2022 | 3.60B | -246.19M | -6.41% |
Dec 31, 2021 | 3.84B | 356.57M | 10.23% |
Dec 31, 2020 | 3.48B | 178.60M | 5.40% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 63.49B |
Novartis AG | 43.89B |
Lonza Group AG | 7.09B |
Alcon | 8.77B |
Galderma Group AG | 3.73B |
Sandoz Group AG | 8.42B |
Straumann Holding AG | 2.50B |
Sonova Holding AG | 3.87B |